CDC panel unanimously backs use of Pfizer's COVID-19 vaccine in young children

Advisers to the Centers for Disease Control and Prevention unanimously recommended Pfizer and BioNTech's coronavirus vaccine for use in children between 5 and 11 years old, setting up a new wave of immunizations to begin shortly in the U.S.